Drug Shortage Report for LACTULOSE SOLUTION USP
| Report ID | 38532 |
| Drug Identification Number | 02242814 |
| Brand name | APO-LACTULOSE |
| Common or Proper name | LACTULOSE |
| Company Name | BAJAJ MEDICAL, LLC |
| Market Status | CANCELLED (UNRETURNED ANNUAL) |
| Active Ingredient(s) | LACTULOSE |
| Strength(s) | 667MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL |
| Packaging size | 1 L |
| ATC code | A06AD |
| ATC description | DRUGS FOR CONSTIPATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-07-09 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2018-09-07 |
| Shortage status | Resolved |
| Updated date | 2018-09-07 |
| Company comments | no production planned for the foreseeable future |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 415 W PERSHING RD CHICAGO, ILLINOIS UNITED STATES 60609 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-09-07 | French | Compare |
| v4 | 2018-09-07 | English | Compare |
| v3 | 2018-07-10 | English | Compare |
| v2 | 2018-02-05 | French | Compare |
| v1 | 2018-02-05 | English | Compare |
Showing 1 to 5 of 5